Treatment for lymphoma and late cardiovascular disease risk: A systematic review and meta-analysis.

Chelsea R StoneAlexis T MickleDevon J BoyneAliya MohamedDoreen M RabiDarren R BrennerChristine M Friedenreich

Published in: Health science reports (2019)

Given the suggested increased risks of cardiovascular outcomes in lymphoma survivor populations relative to the general population, tailored screening and prevention programmes may be warranted to offset the future burden of disease.

Keyphrases

cardiovascular disease
diffuse large b cell lymphoma
current status
smoking cessation
human health
combination therapy
climate change
replacement therapy